Adenosine inhibits leukocyte-induced vasoconstriction

Am J Physiol. 1996 Dec;271(6 Pt 2):H2622-8. doi: 10.1152/ajpheart.1996.271.6.H2622.

Abstract

Polymorphonuclear leukocytes (PMNs) can induce endothelium-dependent constriction of vascular rings. Because adenosine inhibits the function of PMNs, we examined the effects of adenosine on the PMN-induced coronary vasoconstriction. We measured changes in the isometric tension of isolated rings of canine coronary arteries suspended in an organ chamber filled with Krebs-Henseleit solution after the addition of autologous PMNs. N-formyl-L-methionyl-leucyl-phenylalanine (FMLP)-stimulated PMNs increased the tension of the coronary artery with the endothelium in a concentration-dependent manner. Treatment of FMLP-stimulated PMNs with adenosine inhibited both the adhesion of PMNs to the endothelium and the PMN-induced vasoconstriction. Stimulation of PMNs with CGS-21680C, but not with cyclohexyladenosine, inhibited both the adhesion of PMNs to the endothelium and the PMN-induced vasoconstriction. However, treatment of coronary arteries with adenosine had no effect on the adherence of PMNs to the endothelium and the PMN-induced constriction. These results suggest that stimulation of adenosine A2a receptors on PMNs may inhibit the PMN-induced vasoconstriction by inhibiting the adhesion of PMNs to the endothelium.

MeSH terms

  • Adenosine / pharmacology*
  • Animals
  • Cell Adhesion / drug effects
  • Coronary Vessels / drug effects
  • Coronary Vessels / physiology
  • Dogs
  • Endothelium, Vascular / physiology
  • Female
  • In Vitro Techniques
  • Leukocytes / physiology*
  • Male
  • Neutrophils / drug effects
  • Neutrophils / physiology
  • Vasoconstriction / drug effects*
  • Vasoconstriction / physiology*
  • Vasodilator Agents / pharmacology*

Substances

  • Vasodilator Agents
  • Adenosine